You might also read
Articles linked to this work by shared authors, journal, and citation graph.
1Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
Developing novel anti-influenza drugs targeting virus entry is crucial due to increasing drug resistance. This review examines influenza entry inhibitors and their clinical trial performance, offering insights into future antiviral strategies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: